Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ozanimod
ozanimod
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Celgene to launch five new products through to 2020
PM Live
Mon, 10/29/18 - 07:02 pm
Celgene
Revlimid
FDA
fedratinib
ozanimod
luspatercept
bb2121
liso-cel
Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
CP Wire
Wed, 10/10/18 - 10:10 am
Celgene
ozanimod
multiple sclerosis
Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
Wed, 10/10/18 - 09:50 am
Celgene
ozanimod
multiple sclerosis
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Medical Marketing and Media
Wed, 07/18/18 - 10:49 pm
Celgene
Novartis
ozanimod
Gilenya
MS
multiple sclerosis
patents
Pharma's 2 Biggest Setbacks in 2018
Motley Fool
Sun, 07/1/18 - 11:29 am
AbbVie
Celgene
Rova-T
ozanimod
Celgene executive blames Receptos for ozanimod filing fail
Fierce Biotech
Wed, 06/13/18 - 10:27 pm
Celgene
Receptos
ozanimod
Celgene's timeline for refiling ozanimod gets mixed reviews
Biopharma Dive
Sat, 05/5/18 - 10:58 am
Celgene
ozanimod
MS
multiple sclerosis
FDA
A metabolite will make or break Celgene's ozanimod
Biopharma Dive
Sat, 04/28/18 - 11:53 am
Celgene
ozanimod
MS
multiple sclerosis
metabolite
Celgene's Ozanimod Reduces Relapses and Brain Volume Loss in MS Patients in Phase III Trials
CP Wire
Tue, 04/24/18 - 10:31 am
Celgene
ozanimod
relapsing multiple sclerosis
MS
Celgene's Ozanimod Reduces Relapses and Brain Volume Loss in MS Patients in Phase III Trials
Tue, 04/24/18 - 09:25 am
Celgene Corporation
multiple sclerosis
ozanimod
Arena Pharmaceuticals Takes Aim at Celgene
Motley Fool
Fri, 03/23/18 - 09:35 pm
Arena Pharmaceuticals
Celgene
etrasimod
ozanimod
ulcerative colitis
How Bad Is Celgene's FDA Foul-Up? Two Decades Of Biotech History Says It Can't Be Good
Forbes
Wed, 02/28/18 - 12:21 pm
Celgene
biotech
FDA
RTF letters
ozanimod
Celgene stumbles again, as FDA declines to review multiple sclerosis drug critical to company future
Stat
Tue, 02/27/18 - 06:47 pm
Celgene
FDA
MS
multiple sclerosis
ozanimod
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
Motley Fool
Wed, 02/14/18 - 11:20 am
Celgene
etrasimod
ozanimod
Arena Pharmaceuticals
MS
multiple sclerois
3 Big Biotech Stocks With Major Catalysts on the Way
Motley Fool
Tue, 01/30/18 - 09:50 am
biotech
AbbVie
Neurocrine Biosciences
Elagolix
Celgene
ozanimod
Gilead Sciences
bictegravir
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Gilead Sciences
Bictegravir/F/TAF
Novo Nordisk
semaglutide
Ozempic
Incyte
epacadostat
AbbVie
Rova-T
Celgene
ozanimod
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
Late-stage ozanimod data brings Celgene closer to filing
BioPharma Dive
Mon, 10/30/17 - 02:56 pm
ozanimod
Celgene
MS
multiple sclerosis
How Big of a Deal Is Celgene's Flop?
Motley Fool
Sat, 10/21/17 - 10:23 am
Celgene
GED-301
Crohn’s disease
ozanimod
Otezla
Pages
« first
‹ previous
1
2
3
4
next ›
last »